The 2024–26 parliamentary session has seen significant activity across health and social care, with a number of key legislative developments now shaping the future of the sector.
Following the end of the 2024-26 parliamentary session, our latest report provides a clear and concise overview of three major pieces of health legislation that progressed during that session: the Rare Cancers Act 2026, the Terminally Ill Adults (End of Life) Bill, and the Tobacco and Vapes Act 2026.
In this report, we explore:
– The objectives behind each piece of legislation
– Stakeholder perspectives and areas of debate
– The potential impact on public health and patient safety
To download the full report, simply fill out the form below:
Our latest research
The Renewed Women’s Health Strategy sets out 117 action points and £72m in funding commitments. Responsibility for delivery has now passed to a new Government, and the DHSC has had three Health Secretaries i…
What does the Budget mean for the future of Transport and Infrastructure? Georgia Harris, Political Consultant at Dods, considers the key announcements, remaining uncertainties and what they could mean for the …
Mia Terra St. Hill, Political Consultant for Justice and Home Affairs at Dods, explores the key announcements, what remains unaddressed, and the wider implications for the sector. What are the key takeaways for…
What does the Budget mean for the future of housing and local government? Georgia Harris, Political Consultant at Dods, considers the key announcements, remaining uncertainties and what they could mean for the …
Joshua Opeaye:, Political Consultant for Health and Life Sciences at Dods, examines the key announcements, outstanding policy questions and what the Budget signals for the future of the sector. What are the key…
What does the 2026 Budget mean for Business, Innovation, Science & Trade? Ben Pegrum, Political Consultant for Science, Innovation and Technology at Dods, examines the key announcements, outstanding policy …
